Citations 0
February 2, 2005

Medicare Drug Beneficiaries and Cost-Lowering Strategies

Author Affiliations

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2005;293(5):552-553. doi:10.1001/jama.293.5.552-b

To the Editor: In their study of the consequences of exceeding a drug benefit cap, Dr Tseng and colleagues1 found that some patients with chronic diseases discontinued prescribed medications for financial reasons. The authors concluded that clinicians, insurers, and the public need to consider strategies to maximize benefit from Medicare drug coverage plans and mentioned reimportation of prescription drugs as a possibility. However, alternatives exist that may help reduce drug expenses.

First Page Preview View Large
First page PDF preview
First page PDF preview